Impact of protein restriction on the regulation of cardiac carnitine palmitoyltransferase by malonyl-CoA

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 7, 1998, Pages 1381-1390

  Holness, Mark J ^a   Priestman, David A ^a   Sugden, Mary C ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cardiac myocytes; Fatty acid oxidation; Glucose utilization; Heart

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; FATTY ACID; GLUCOSE; HEART ENZYME; MALONYL COENZYME A; PALMITIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; FATTY ACID OXIDATION; FEMALE; GLUCOSE UTILIZATION; HEART MITOCHONDRION; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; POSTNATAL DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; PROTEIN MALNUTRITION; PROTEIN RESTRICTION; RAT; WEANING;

EID: 0032128379     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0709     Document Type: Article

References (36)

1. AWAN MM, SAGGERSON ED, 1993. Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem J 295: 61-66.
2. BARKER DJP, 1993. Fetal origins of coronary heart disease. Br Heart 69: 195-196.
3. BARKER DJP, 1994. Maternal and fetal origins of coronary heart disease. J Roy Coll Phys London 281: 544-551.
4. BARKER DJP, 1995. Fetal origins of coronary heart disease. BMJ 311: 171-174.
5. BARKER DJP, GLUCKMAN PD, GODFREY KM, HARDING JE, OWENS JA, ROBINSON JS, 1993a. Fetal nutrition and cardiovascular disease in adult life. Lancet 341: 938-941.
6. BARKER DJP, HALES CN, FALL CHD, OSMOND C, PHIPPS K, CLARK PMS, 1993b. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36: 62-67.
7. BARKER DJP, OSMOND C, SIMMONDS SJ, WIELD GA, 1993c. The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ 306: 422-426.
8. BROWN NF, WEIS BC, HUSTI JE, FOSTER DW, MCGARRY JD, 1995. Mitochondria carnitine palmitoyltransferase I isoform switching in the developing rat heart. J Biol Chem 270: 8952-8957.
9. DAHRI S, SNOECK A, REUSENS-BILLEN B, REMACLE C, HOET JJ. 1991. Islet function in offspring of mothers on low-protein during gestation. Diabetes 40: 115-120.
10. DESAI M, CROWTHER NJ, OZANNE SE, LUCAS A, HALES CN, 1995. Adult glucose and lipid metabolism may be programmed during fetal life. Biochem Soc Trans 23: 331-335.
11. DRYNAN L, QUANT PA, ZAMMIT VA, 1996. The role of changes in the sensitivity of hepatic mitochondrial overt carnitine palmitoyltransferase in determining the onset of the ketosis of starvation in the rat. Biochem J 318: 767-770.
12. FERRÉ P, LETURQUE A, BURNOL A-F, PÉNICAUD L, GIRARD J, 1985. A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anaesthetized rat. Biochem J 228: 103-110.
13. HOLNESS MJ, 1996. The impact of early growth retardation on glucoregulatory control and insulin action in mature rats. Am J Physiol 270: E946-E954.
14. HOLNESS MJ, SUGDEN MC, 1990. Glucose utilization in heart, diaphragm and skeletal muscle during the fed-to-starved transaction. Biochem J 270: 245-249.
15. HOLNESS MJ, SUGDEN MC, 1996. Suboptimal protein nutrition in early life later influences insulin action in pregnant rats. Diabetologia 39: 12-21.
16. LANGLEY SC, JACKSON AA, 1994. Increased systolic blood pressure in adult rats induced by fetal exposure to maternal low protein diets. Clin Sci 86: 217-222.
17. LANGLEY-EVANS SC, JACKSON AA, 1995. Captrorpril normalises systolic blood pressure in rats with hypertension induced by fetal exposures to maternal low protein diets. Comp Biochem Physiol Biochem Mol Biol 110: 223-226.
18. LEDERMAN S, ROSSO P, 1981. Effects of fasting during pregnancy on maternal and fetal weight and body composition in well-nourished and undernourished rats. J Nutr 111: 1823-1832.
19. LOPASCHUK GD, WAMBOLT RB, BARR RL. 1993. An imbalance between glycolysis and glucose oxidation is a possible explantation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 264: 135-144.
20. LOPASCHUK GD, BELKE DD, GAMBLE J, SCHONEKESS BO, 1994. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213: 263-276.
21. LOPASCHUK GD, 1996. Abnormal mechanical function in diabetes: relationships to altered myocardial carbohydrate/lipid metabolism. Coronary Artery Disease 7: L116-L123.
22. LOPASCHUK GD, SPAFFORD M. 1989. Response of isolated working hearts from acutely and chronically diabetic rats to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow. Circ Res 65: 378-387.
23. MCGARRY JD, 1995a. The mitochondrial carnitine palmitoyltransferase system: its broadening role in fuel homeostasis and new insights into its molecular features. Biochem Soc Trans 23: 321-324.
24. MCGARRY JD, 1995b. Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership. Biochem Soc Trans 23: 481-485.
25. MCGARRY JD, MILLS SE, LONG CS, FOSTER DW, 1983. Observations on the affinity for carnitine, and maltonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonatration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 214: 21-28.
26. NICHOLL TA, LOPASCHUK GD, MCNEIL JH, 1987. The effects of free fatty acids and dichloroacetate on the isolated working diabetic rat heart. Am J Physiol 261: H1053-H1059.
27. ORFALI KA, FRYER LG, HOLNESS MJ, SUGDEN MC, 1993. Long-term regulation of pyruvate dehydrogenase kinase by high-fat feeding. Experiments in vivo and in cultured cardiomyocytes. FEBS Lett 336: 501-505.
28. OZANNE SE, SMITH GD, TIKERPAE J, HALES CN, 1996. Altered regulation of hepatic glucose output in the male offspring of protein-malnourished rat dams. Am J Physiol 270: E559-E564.
29. PRIP-BUUS C, THUMELIN S, CHATELAIN F, PEGOORIER JP, GIRARD J, 1995. Hormonal and nutritional control of liver fatty acid oxidation and ketogenesis during development. Biochem Soc Trans 23: 500-506.
30. SUGDEN MC, HOLNESS MJ, 1994. Interactive regulation of the pyruvate dehydrogenase complex and the carnitine palmitoyltransferase system. FASEB J 8: 54-61.
31. SUGDEN MC, HOLNESS MJ, 1995. Modulation of in vivo insulin action by dietary protein during pregnancy. Am J Physiol 268: E722-E729.
32. SUGDEN MC, ORFALI KA, FRYER LGD, HOLNESS MJ, PRISTMAN DA, 1997. Molecular mechanisms underlying the long-term impact of dietary fat to increase cardiac pyruvate dehydrogenase kinase. Regulation by insulin, cyclic AMP and pyruvate. J Mol Cell Cardiol 29: 1867-1875.
33. WEIS BC, COWAN AT, BROWN N, FOSTER DW, MCGARRY JD, 1994a. Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme. J Biol Chem 269: 26443-26448.
34. WEIS BC, ESSER V, FOSTER DW, MCGARRY JD, 1994b. Rat heart expresses two forms of mitochondrial carnitine palmitoyltransferase I. The minor component is identical to the liver enzyme. J Biol Chem 269: 18712-18715.
35. YAMAZAKI N, SHINOHARA M, SHIMA A, TERADA H, 1995. High expression of a novel carnitine palmitoyltransferase I like protein in rat brown adipose tissue and heart: isolation and characterization of its cDNA clone. FEBS Lett 363: 41-45.
36. YU G, LU Y-C, GULICK T, 1997. Expression of novel carnitine palmitoyltransferase I mRNA splice variants in human heart: implications for myocardial fatty acid β oxidative metabolism. Circulation 96 (Suppl. 1): 691.